Market Overview

UPDATE: Bank of America Merrill Lynch Initiates Coverage on Mylan with Overweight Rating

Related MYL
EXCLUSIVE: FBB's Mike Bailey On Pfizer-Allergan Deal, Taxes, Rate Hike And Biotech Picks
Benzinga's Top #PreMarket Gainers
Tracking Ruane, Cunniff & Goldfarb's Portfolio - Q3 2015 Update (Seeking Alpha)

In a report published Monday, Bank of America Merrill Lynch initiated coverage on Mylan (NASDAQ: MYL) with an Overweight rating.

BofA Merrill Lynch noted, “We initiate coverage on Mylan at OW-100%, as we see material yield and promising long-term growth prospects vs. peers within the IG Pharma subsector. Moody's and S&P upgraded Mylan to investment grade last week mainly due to its strong positioning in the generics market and favorable financial policies.”

Mylan closed on Friday at $27.11.

Latest Ratings for MYL

Nov 2015Leerink SwannMaintainsOutperform
Sep 2015BarclaysInitiates Coverage onEqual-weight
Aug 2015Standpoint ResearchInitiates Coverage onBuy

View More Analyst Ratings for MYL
View the Latest Analyst Ratings

Posted-In: Bank of America Merrill LynchAnalyst Color Initiation Analyst Ratings


Related Articles (MYL)

Get Benzinga's Newsletters